Concepedia

Z Wang

ZW

Statistics

Publications

2

Citations

755

H-Index

2

Active since

1997

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Z Wang is an author at Merck Canada Inc. (Canada) specializing in cyclooxygenase inhibitors, drug discovery, and medicine.

Publications per year

1997–1999

2

Publications

2

The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

Petpiboon Prasit, Z Wang, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 429 citations · Full text

, , +9

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor

Denis Riendeau, M. David Percival, S. Boyce et al. · British Journal of Pharmacology · 1997 · 326 citations · Full text

, , +13

1–2 of 2